Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Recurrence × Observation × Clear all

Phase

Status

Completed 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Multiple Myeloma 2 Colorectal Neoplasms 2 Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Tubular Adenocarcinoma 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Infections 1 Hemangioma, Cavernous, Central Nervous System 1 Hemangioma 1 Head and Neck Neoplasms 1 Gallbladder Neoplasms 1 Gallbladder Cancer Unresectable 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Cancer-Related Condition 1 Cachexia 1 Brenner Tumor 1 Biliary Tract Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

Cyclophosphamide 16 fludarabine 12 Cisplatin 11 Rituximab 9 Dexamethasone 9 Gemcitabine 8 Cytarabine 7 fludarabine phosphate 6 Paclitaxel 6 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 6 Lenalidomide 6 Decitabine 6 Radiotherapy 5 Etoposide 5 Carboplatin 5 Bendamustine Hydrochloride 5 camrelizumab 4 apatinib 4 Valproic Acid 4 Thalidomide 4 Procarbazine 4 Oxaliplatin 4 Injections 4 Bortezomib 4 Antilymphocyte Serum 4 tislelizumab 3 pomalidomide 3 Vinorelbine 3 Vinblastine 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02572492 2018-08-17

CARFI

Aalborg University Hospital

Phase 2 Unknown

Multiple Myeloma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡